Publicaciones en las que colabora con Alberto Ocaña (5)

2014

  1. Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer

    Oncogene, Vol. 33, Núm. 2, pp. 148-156

2009

  1. Expression of Erk5 in early stage breast cancer and association with disease free survival identifies this kinase as potential therapeutic target

    PLoS ONE, Vol. 4, Núm. 5

2008

  1. Third nerve palsy as the initial presenting sign of metastatic prostate cancer

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 31, Núm. 4, pp. 407-408

2007

  1. Neuregulin expression modulates clinical response to trastuzumab in patients with metastatic breast cancer

    Journal of Clinical Oncology, Vol. 25, Núm. 19, pp. 2656-2663

  2. Papel de Erk5 en cáncer de mama

    Papel de Erk5 en cáncer de mama